Cogent Biosciences : COGT

COGT

Stock Data

$36.63

$0.84 (2.35%)

Asset Type

Common Stock

Exchange

NASDAQ

Currency

USD

Country

USA

Sector

HEALTHCARE

Industry

BIOTECHNOLOGY

Cogent Biosciences Inc, based in Waltham, Massachusetts, is a pioneering biotechnology firm dedicated to creating targeted treatments for genetic diseases. Its flagship product, bezuclastinib, is a cutting-edge therapy aimed at combating specific mutations in the KIT receptor tyrosine kinase, crucial for conditions like systemic mastocytosis and certain gastrointestinal stromal tumors. With a strategic partnership with Plexxikon Inc., Cogent is at the forefront of personalized medicine, transforming the landscape of treatment for patients with complex genetic disorders.